Criteria for TNF-Targeted Therapy in Rheumatoid Arthritis: Estimates of the Number of Patients Potentially Eligible

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.12, 2001-01, pp. : 1711-1720

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted therapy in rheumatoid arthritis

By Kller Marcus D

Expert Opinion on Drug Discovery, Vol. 3, Iss. 3, 2008-03 ,pp. : 329-342

Informa Healthcare

Access to resources Recommend Favorite

TNF inhibition as therapy for rheumatoid arthritis

By Wollheim Frank A

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. : 947-953

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

By Coenen Marieke JH Toonen Erik JM Scheffer Hans Radstake Timothy RDJ Barrera Pilar Franke Barbara

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 761-773

Future Medicine

Access to resources Recommend Favorite

According to The British Society for Rheumatology guidelines, 5.6% of outpatients with rheumatoid arthritis (RA) in the West Midlands, UK, are eligible for anti-tumour necrosis factor (TNF) monoclonal antibody therapy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

TNF- inhibitors and rheumatoid arthritis

By Shire M.G. Muller G.W.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 5, 1998-05 ,pp. : 531-544

Informa Healthcare

Access to resources Recommend Favorite